CD27 and relapsing-remitting multiple sclerosis: Directly comparing glioblastoma and RRMS patients, higher fractions of CD5+ activated TZB (Bc 11) and CD24+/CD27+ Bregs (Bc 19) were noted in the PB of RRMS patients.